Inventiva S.A.

IVANASDAQHealthcareBiotechnology

$3.66- (-)1Y −38.67%

As of Oct 26, 2026 close

Market cap: $1.00B
P/E (TTM): -
Forward P/E: -
Dividend yield: -
52-week range: $2.82$7.98
Volume (live): -
Avg. volume (3M): 3.03M

Inventiva S.A. (IVA) Analyst Forecast

Analyst consensus ratings, 12-month price targets, and expert recommendations for Inventiva S.A. stock.

Analyst Consensus Rating

Investment consensus from 9 professional research analysts

Consensus Rating

Buy

Based on 9 unique analysts

(12 total ratings in last 90 days)

Medium Confidence∞:1 Buy/Sell

Average Price Target

$15.50

+320.62% upside

Loading chart...

Strong Sell

Sell

Hold

Buy

Strong Buy

Latest IVA Analyst Ratings & Recommendations

Recent analyst recommendations with rating changes and price target updates (last 90 days)

Date	Analyst	Firm	Action	Rating	Price Target
Oct 23, 2026	Yasmeen Rahimi	Piper Sandler	Maintains	Buy	$26.00
Oct 2, 2026	Srikripa Devarakonda	Truist	Reiterates	Buy	-
Sep 30, 2026	Thomas Smith	Leerink Partners	Reiterates	Buy	$12.00
Sep 30, 2026	Michael Yee	UBS	Maintains	Buy	$12.00
Sep 29, 2026	Edward Nash	Canaccord Genuity	Reiterates	Buy	$20.00 → $21.00 +1.00 (+5.0%)
Sep 29, 2026	Seamus Fernandez	Guggenheim	Reiterates	Buy	$14.00
Sep 29, 2026	Ritu Baral	TD Cowen	Maintains	Buy	$10.00
Sep 28, 2026	Rami Katkhuda	LifeSci Capital	Maintains	Buy	$14.00
Sep 28, 2026	Seamus Fernandez	Guggenheim	Reiterates	Buy	$14.00
Sep 28, 2026	Ritu Baral	TD Cowen	Maintains	Buy	$10.00
Sep 23, 2026	Annabel Samimy	Stifel Nicolaus	Reiterates	Buy	$15.00
Sep 16, 2026	Yasmeen Rahimi	Piper Sandler	Maintains	Buy	$26.00

Yasmeen Rahimi

Piper Sandler

BuyMaintains

$26.00

Oct 23

Srikripa Devarakonda

Truist

BuyReiterates

Oct 2

Thomas Smith

Leerink Partners

BuyReiterates

$12.00

Sep 30

Michael Yee

UBS

BuyMaintains

$12.00

Sep 30

Edward Nash

Canaccord Genuity

BuyReiterates

$20.00 → $21.00

Sep 29

Seamus Fernandez

Guggenheim

BuyReiterates

$14.00

Sep 29

Ritu Baral

TD Cowen

BuyMaintains

$10.00

Sep 29

Rami Katkhuda

LifeSci Capital

BuyMaintains

$14.00

Sep 28

Seamus Fernandez

Guggenheim

BuyReiterates

$14.00

Sep 28

Ritu Baral

TD Cowen

BuyMaintains

$10.00

Sep 28

Annabel Samimy

Stifel Nicolaus

BuyReiterates

$15.00

Sep 23

Yasmeen Rahimi

Piper Sandler

BuyMaintains

$26.00

Sep 16

Source: Professional analyst ratings and price targets from the last 90 days. Data as of Oct 23, 2026. Data sources and methodology

Frequently Asked Questions

What is the analyst consensus rating for IVA?

The analyst consensus rating for IVA is Buy, based on the latest ratings from 9 analysts over the last 90 days.

What is the average price target for IVA?

The average 12-month price target for IVA is $15.50, representing an upside of 320.6% from the Oct 27, 2026 close of $3.69.

What do analyst ratings mean?

Analyst ratings indicate investment recommendations: Strong Buy and Buy are bullish signals suggesting the stock may outperform. Hold means the stock is fairly valued. Sell and Strong Sell are bearish signals suggesting potential underperformance. These ratings are based on fundamental analysis and valuation models.

What is a price target?

A price target is an analyst's projection of a stock's fair value over a specific timeframe, typically 12 months. Analysts use fundamental analysis, financial modeling, and industry comparisons to estimate where the stock should trade. Price targets can range from low (conservative) to high (optimistic) estimates.